(Q43717719)
Statements
1 reference
Comparison of the clinical success and quality-of-life impact of brimonidine 0.2% and betaxolol 0.25 % suspension in patients with elevated intraocular pressure (English)
1 reference
L B Cantor
1 reference
J Hoop
1 reference
L J Katz
1 reference
K Flartey
1 reference
Alphagan/Betaxolol Clinical Success Study Group
1 reference
1 July 2001
1 reference
1 reference
23
1 reference
7
1 reference
1032-1039
1 reference
Identifiers
1 reference
1 reference